Featured Research

from universities, journals, and other organizations

National Jewish Medical And Research Center Immunologist Weighs In On Flu Inhalers

Date:
January 12, 2000
Source:
National Jewish Medical And Research Center
Summary:
A flu shot is given in the muscle, which leads to a systemwide production of antibodies that protect the body from the flu virus. Inhaled flu medication works topically and systemically, protecting you from air-borne infection.

Q: Is it better to use a flu inhaler or get a flu shot?

A: Each is effective in its own way in specific situations and can be used depending on a person’s health situation.

A flu shot is given in the muscle, which leads to a systemwide production of antibodies that protect the body from the flu virus. Flu inhalers came about because of the effectiveness of inhalers for illnesses such as asthma. Inhaled flu medication works topically and systemically, protecting you from air-borne infection.

Everything being equal, you should get a flu shot each year unless your doctor indicates otherwise because it’s the best preventative measure. For older people who have health issues such as cardiac problems, the flu can be extremely devastating. It is important to guard against it. Getting a flu shot every year is the best method of warding off the flu. Yearly flu shots build immunity to the most common strains that are in the environment that year. New viruses are still variations on the common strains, so you do have protection against new viruses with yearly shots.

Some people, those living in nursing homes, for example, may not be able to have a flu shot, due to other health problems. For those who cannot receive the shot, the new inhaled or oral flu treatments are good alternatives. Also, a person who does not make antibodies, and therefore can’t take a muscular shot, could use these flu inhibitors to prevent infection.

An inhaled flu medication, zanamivir, is one of a new type of drug that is effective against both type A and type B flu strains, the major strains of flu. Zanamivir and similar new drugs are the first to be effective against both major types of viruses. Some forms of this new type of drug, such as oseltamivir, are taken orally. Both require a doctor’s prescription.

The flu inhaler should be used within 24 to 36 hours of the time you feel flu symptoms, such as body aches. One inhaler is good for about five or six days. A month later you may need treatment again because the initial dosage offers protection for a limited time. Also, zanamivir is expensive. A course of treatment is about $50, nearly four times the price of a flu shot.

For more information, call LUNG LINE, (800) 222-LUNG, e-mail, lungline@njc.org or visit our Web site, www.nationaljewish.org/pa.

  • James Jones, M.D., treats people with immune system diseases at National Jewish Medical and Research Center in Denver

NOTE: A patient should consult his or her personal physician before changing or considering any medical treatments.


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "National Jewish Medical And Research Center Immunologist Weighs In On Flu Inhalers." ScienceDaily. ScienceDaily, 12 January 2000. <www.sciencedaily.com/releases/2000/01/000111110818.htm>.
National Jewish Medical And Research Center. (2000, January 12). National Jewish Medical And Research Center Immunologist Weighs In On Flu Inhalers. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2000/01/000111110818.htm
National Jewish Medical And Research Center. "National Jewish Medical And Research Center Immunologist Weighs In On Flu Inhalers." ScienceDaily. www.sciencedaily.com/releases/2000/01/000111110818.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins